Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	412	355	112	71	106	197
Market Cap Growth	50.51%	215.68%	57.54%	-32.42%	-46.38%	53.54%
Enterprise Value	407	339	96	64	90	197
Last Close Price	15.45	13.32	4.38	2.82	4.29	8.13
Forward PE	15.42	57.91	79.64	-	9.98	-
PS Ratio	5.87	9.09	3.55	3.36	4.84	5047.59
PB Ratio	17.92	14.52	7.26	5.46	5.99	12.57
P/TBV Ratio	-	-	10.47	8.57	7.54	13.05
P/FCF Ratio	19.65	376.22	16.49	14.92	-	-
P/OCF Ratio	19.38	366.13	16.49	14.80	-	-
EV/Sales Ratio	5.78	8.69	3.04	3.03	4.11	5040.62
EV/FCF Ratio	19.36	359.32	14.11	13.46	-	-
Debt / Equity Ratio	1.34	1.23	0.35	0.50	0.38	0.46
Debt / FCF Ratio	1.47	31.81	0.80	1.36	-	-
Asset Turnover	1.00	0.72	1.12	0.81	0.81	0.00
Inventory Turnover	3.25	1.93	14.42	12.53	3.16	0.54
Quick Ratio	1.14	1.02	1.53	2.81	4.36	5.63
Current Ratio	1.63	2.06	1.65	3.10	5.18	6.51
Return on Equity (ROE)	-34.17%	-19.16%	-6.56%	-58.75%	-11.74%	-213.40%
Return on Assets (ROA)	1.26%	-2.53%	-2.63%	-19.67%	-3.47%	-78.10%
Return on Capital (ROIC)	2.37%	-3.62%	-3.68%	-23.51%	-3.96%	-89.38%
Return on Capital Employed (ROCE)	2.30%	-3.90%	-7.70%	-44.50%	-6.50%	-120.40%
Earnings Yield	-1.62%	-1.08%	-0.83%	-12.65%	-1.85%	-14.21%
FCF Yield	5.09%	0.27%	6.06%	6.71%	-4.48%	-11.38%
Buyback Yield / Dilution	-3.52%	-0.97%	-1.99%	0.24%	-19.98%	-18.30%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q